Clinical trial
TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal…
NCT00241163 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00241163 |
|---|---|
| Title | TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) |
| Official title | An Open, Randomised, Prospective, Multicentre, Parallel-group Trial to Compare Efficacy and Safety of TachoComb S Versus Standard Surgical Treatment in Patients Undergoing Surgical Resection of Superficial Renal Tumour. |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Surgical Resection of Superficial Renal Tumour |
| Intervention type | Procedure |
| Interventions | Fibrinogen (human) + thrombin (human) (TachoSil) |
| Enrollment | 170 |
| First posted | Oct 18, 2005 |
| Last update posted | Aug 3, 2012 |
| Countries | Denmark |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: